Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes One RNAi-Related Patent Application: Apr 12, 2007

Premium
Title: Bioinformatically Detectable Group of Novel Vaccina Regulatory Genes and Uses Thereof
 
Number: 20070077553
 
Filed: Oct. 30, 2003
 
Inventor: Isaac Bentwich, Rosetta Genomics
 
The invention “relates to a group of novel viral RNA regulatory genes, here identified as viral genomic address messenger genes or VGAM genes, and as viral genomic record or VGR genes,” according to the patent application’s abstract. “VGAM genes selectively inhibit translation of known host target genes and are believed to represent a novel pervasive viral attack mechanism. VGR genes encode an operon-like cluster of VGAM genes. VGAM and viral VGR genes may therefore be useful in diagnosing, preventing and treating viral disease,” the abstract adds. “Several nucleic acid molecules are provided respectively encoding several VGAM genes, as are vectors and probes, both comprising the nucleic acid molecules, and methods and systems for detecting VGAM genes, and for counteracting their activity.”

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.